FDA Actions Against Health Economic Promotions, 2002–2011
Authors:
- Peter J. NeumannPNPeter J. Neumann
- Sarah K. BlissSBSarah K. Bliss
- 18 June 2012
- journal article
- Published by Elsevier in Value in Health
- Vol. 15 (6) , 948-953
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- US FDA Modernization Act, Section 114PharmacoEconomics, 2011
- What Ever Happened to FDAMA Section 114? A Look back after 10 YearsValue in Health, 2009
- Drug Company Advertising in Medical Journals About the Health-Economic Advantages of Their Products for 2000-2006 Versus 1990-1999Journal of Managed Care Pharmacy, 2008
- FDA Actions against Misleading or Unsubstantiated Economic and Quality-of-Life Promotional Claims: An Analysis of Warning Letters and Notices of ViolationValue in Health, 2002
- Economic Messages in Prescription Drug Advertisements in Medical JournalsMedical Care, 2002
- US Regulation of Pharmaceutical Outcomes Research Presented at the ISPOR 5th Annual International Meeting, Crystal City, VA, 24 May 2000Value in Health, 2001
- The freedom of information act and the 2600 ClubNetwork Security, 1996